Table 2.
Characteristics of the study population before and after 8 weeks.
| Plant-Based Group (n = 18) | Control Group (n = 19) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | Week 8 | Δ [95% CI] | Baseline | Week 8 | Δ [95% CI] | p-Value * | |
| Anthropometrics | |||||||
| Weight [kg] | 93.0 ± 16.6 | 89.5 ± 15.5 | −3.5 [−5.3–−1.7] | 80.7 ± 11.9 | 80.4 ± 12.1 | −0.3 [−1.1–0.5] | 0.002 |
| Body mass index [kg/m2] | 31.7 ± 4.6 | 30.5 ± 4.1 | −1.2 [−1.8–−0.6] | 29.5 ± 4.5 | 29.4 ± 4.8 | −0.1 [−0.4–0.3] | 0.002 |
| Waist circumference [cm] | 109.9 ± 11.1 | 106.7 ± 9.4 | −3.2 [−5.1–−1.3] | 101.2 ± 7.0 | 101.5 ± 7.1 | 0.2 [−0.9–1.4] | 0.004 |
| Laboratory data | |||||||
| Fasting blood glucose [mg/dl] | 99.7 ± 15.5 | 93.9 ± 12.9 | −5.8 [−9.1–−2.6] | 93.1 ± 16.2 | 92.5 ± 15.1 | −0.6 [−3.9–2.8] | 0.042 |
| HbA1c [mmol/mol] | 40.1 ± 6.5 | 38.4 ± 5.4 | −1.7 [−2.8–−0.6] | 36.5 ± 3.1 | 36.8 ± 3.8 | 0.3 [−0.5–1.2] | 0.009 |
| HOMA Index | 3.7 ± 2.7 | 2.9 ± 1.8 | −0.8 [−1.4–−0.1] | 2.6 ± 1.9 | 2.4 ± 1.7 | −0.2 [−0.6–0.3] | 0.170 |
| Triglycerides [mg/dl] | 112.1 ± 36.5 | 126.6 ± 48.5 | 14.6 [−2.5–31.6] | 120.1 ± 58.1 | 135.6 ± 76.7 | 15.6 [−1.0–32.2] | 0.936 |
| Cholesterol [mg/dl] | 214.1 ± 26.8 | 198.7 ± 28.1 | −15.4 [−27.4–−3.5] | 227.4 ± 46.1 | 223.9 ± 53.7 | −3.5 [−15.5–8.4] | 0.191 |
| LDL [mg/dl] | 137.3 ± 26.0 | 125.0 ± 27.6 | −12.3 [−23.9–−0.7] | 147.4 ± 44.8 | 147.0 ± 52.7 | −0.4 [−11.6–10.8] | 0.171 |
| HDL [mg/dl] | 63.6 ± 15.9 | 56.3 ± 13.4 | −7.4 [−10.1–−4.7] | 66.3 ± 21.1 | 62.4 ± 20.2 | −3.9 [−6.9–−0.9] | 0.117 |
| Ambulatory blood pressure monitoring | |||||||
| ABPM SBP [mm Hg] | 135.9 ± 11.0 | 130.3 ± 14.7 | −5.6 [−10.6–−0.5] | 130.6 ± 13.3 | 131.9 ± 13.1 | 1.3 [−3.5–6.1] | 0.088 |
| ABPM DBP [mm Hg] | 83.3 ± 8.8 | 80.1 ± 9.3 | −3.2 [−6.2–−0.3] | 76.9 ± 5.8 | 78.0 ± 6.8 | 1.1 [−1.8–3.9] | 0.069 |
Data is presented as mean ± SD; the difference is depicted as mean and 95% Confidence Interval; * p-value between groups was determined using a two samples t-test.